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Abstract Dysplasia of the oral, laryngeal and oropha-
ryngeal stratiﬁed squamous epithelia is a microscopically
deﬁned change that may occur in clinically identiﬁable
lesions including erythroplakia, leukoplakia and erythro-
leukoplakia, lesions that convey a heightened risk for
carcinomatous progression. Dysplastic lesions have been
classiﬁed microscopically according to degree of cytologic
atypia and changes in architectural patterns, usually on a
three part or four part gradation scale. Vocal cord epithelial
lesions are graded according to either the Ljubljana or the
World Health Organization (WHO) system whereas oral
dysplasias are generally classiﬁed according to WHO
criteria. Cytologically atypical cells are considered to
represent precancerous changes predicting an increase risk
for carcinomatous transformation. Inter- and intra-rater
reliability studies among pathologists have disclosed low
correlation coefﬁcients for four part grading systems,
whereas improved agreement is achieved (kappa correla-
tion values) using the Ljubljana systems. Evidence
forwarded by some studies supports the prognostic value of
progressively severe dysplastic changes for carcinomatous
transformation; however, some studies indicate that the
presence of a clinically deﬁned lesion without microscopic
evidence of dysplasia also connotes increased risk for
carcinomatous transformation. Loss of heterozygosity
(LOH) at 3p and 9p microsatellite domains, DNA ploidy
analysis and nuclear image analyses may have predictive
value as molecular and histomorphological biomarkers.
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Introduction
Precancerous lesions of the upper aerodigestive tract
keratinizing epithelium include leukoplakia, erythroplakia
and mixed leukoerythroplakia (hyperplastic epithelial
lesions). These clinically deﬁned lesions have been stated
to harbor an increased risk compared to normal mucosa
for transformation into squamous cell carcinoma. When
histopathologic evidence of cytologic and architectural
atypism is present in the absence of invasion, the lesions
are referred to as dysplastic and the presence of dysplasia
has been considered to represent an increased risk iden-
tiﬁer for malignant transformation over that of squamous
lesions that fail to show dysplastic features [1, 2]. This
review will deﬁne the microscopic features encountered in
various grading systems of upper aerodigestive tract
squamous dysplasia, discuss diagnostic reliability among
pathologists, tabulate data on prognostication relative to
carcinomatous transformation and review potential
molecular and biomarker predictors.
Grading Systems
Dysplasias have been subdivided according to the degree
of architectural and cytologic atypia. These grading sys-
tems have been evaluated for their prognostic utility with
the assumption that mild atypical changes will have a lower
risk for transformation to invasive carcinoma than those
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frequently employed systems in use among pathologists
include the World Health Organization (WHO) and the
Ljubljana Grading systems for vocal cord lesions; oral
precancerous lesions are typically classiﬁed according to
WHO [3–6]. The WHO grading system for both vocal cord
and oral mucosa divides dysplasia into three categories,
with the realization that dysplastic change is in reality a
dynamic process. These three stages include mild, moder-
ate and severe dysplasia ﬂanked by hyperplasias or benign
keratoses on the benign end of the spectrum and carcinoma
in situ on the malignant extreme.
Low grade dysplasia is deﬁned as cytologic and archi-
tectural atypia conﬁned to the basal/parabasal layer;
moderate dysplasia is characterized by atypical changes
progressing into the mid spinous layer and severe dysplasia
progresses into the upper spinous layer (Fig. 1). Carcinoma
in situ is characterized by atypical changes from top to
bottom. Many pathologists collapse severe dysplasia and
carcinoma-in situ into a single category. Some pathologists
have applied the cervical dysplasia paradigm to upper air-
way lesions: oral intraepithelial neoplasia (OIN 1, 2 and 3)
or squamous intraepithelial neoplasia (SIN 1, 2 and 3) [7].
The Ljubljana grading system devised in Slovenia by
Kambic and Gale [3, 5] for laryngeal precancerous lesions
divides stages of progressing dysplastic changes into three
categories: ‘‘simple’’ hyperplasia characterized by epithe-
lial thickening without atypical cytologic changes,
‘‘abnormal’’ hyperplasia represented by bulbous rete pegs
and hyperplasia of the basal/parabasilar compartment with
nuclear crowding and enlargement, and ‘‘atypical’’ hyper-
plasia represented by cytologic atypia extending into the
upper strata (Fig. 2). Carcinoma-in situ is reserved for
those lesions with pronounced top to bottom atypia and a
loss of normal stratiﬁcation. Table 1 compares the Ljublj-
ana and WHO models.
Grading Reliability
If any classiﬁcation scheme for upper airway precancerous
lesions is to be employed or universally adopted, it should
be utilitarian. This utility includes reproducibility by
examiner pathologists, both between (interexaminer) and
within (intraexaminer) and lesional grades should have
prognostic value with regard to potential for malignant
transformation to squamous cancer [7]. Investigations that
assess examiner reliability are listed in Table 2. Reliability
data are presented as either % agreement or are expressed
as Kappa statistics. In these studies, a group of examiners is
Fig. 1 The WHO grading
system for oral and laryngeal
precancerous lesions. a. Benign
hyperplasia (benign keratosis),
b. mild dysplasia, c. moderate
dysplasia, d. severe dysplasia,
e. carcinoma in situ
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histopathologic diagnosis on a selection of lesions. Re-
ponses are then compared to assess for agreement or
disagreement. In those studies that address intra-rater cor-
relations, pathologists are assigned a set of glass slides and
render an initial diagnosis and subsequently, at a given
future date, reevaluate the same group of slides and render
a diagnosis while remaining blinded from their initial
diagnoses.
In general, regardless of the grading system chosen,
agreement among pathologists is only fair, kappa values
falling under 0.5. Vocal cord lesional assessment employ-
ing the WHO criteria showed a poor level of agreement;
however, when a binary grading system that included only
two diagnostic categories (mild dysplasia versus severe
dysplasia) were applied, it revealed an improvement in
interrater agreement with a kappa of 0.7 [8]. Among oral
precancerous lesions, using the WHO criteria, kappa values
hover between 0.5 and 0.6 [7–13]. In the investigation by
Kujan et al. [9] a binary grading system did not produce a
higher level of agreement over the WHO system; however,
in the study by Abbey et al. [11] an 80% agreement level
Fig. 2 The Ljubljana grading
system for vocal cord
precancerous lesions.
a. Simple hyperplasia,
b abnormal hyperplasia,
c. atypical (risky) hyperplasia,
d carcinoma in situ
Table 1 Vocal cord dysplasia
Ljubljana System Who System
Simple hyperplasia Benign keratoses
Abnormal hyperplasia Mild dysplasia
Atypical hyperplasia Moderate dysplasia
Several dysplasia
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cases that were dysplastic (any grade) compared to cases
without dysplasia. A similar level of agreement was
observed within pathologists (intra-rater).
These data are somewhat disappointing, being nonre-
producible in many instances. If pathologists cannot agree
on diagnoses for which clinicians plan treatment strategies,
then the system somehow fails unless all lesions regardless
of histology are treated in the same fashion. It is note-
worthy that certain variables factor into disagreement
among pathologists, namely presence or absence of
inﬂammation, lesion site and biopsy method [12].When
pathologists undergo a group training session on what
histopathologic, cytologic and architectural features are
used as criteria for each grade of dysplasia/hyperplasia,
subsequent agreement reliability signiﬁcantly improves
[14].
Prediction of Malignant Transformation
Prognostication should be the outcome goal of histopath-
ologic grading of precancerous lesions of the upper air
passages. Many studies have been undertaken to determine
the prevalence of carcinomatous transformation in clini-
cally deﬁned leukoplakia, erythroplakia, acute laryngitis
(vocal cord erythroplakia) and chronic laryngitis (vocal
cord leukoplakia) [14–23] (Table 3). Five recent follow-up
studies on vocal cord lesions report a range of 3.8–11.2%
malignant transformation rate for all lesions regardless of
histopathology (i.e. both dysplastic and nondysplastic
hyperplasias); a 10.5–32% rate for lesions with histologic
evidence of dysplasia has been reported [14–18]. When
grade of dysplasia using either the WHO or Ljubljana
systems are assessed, there is a progressive increase in
carcinomatous transformation rate with increasing severity
of dysplastic change. Data on oral mucosal dysplasias,
based on ﬁve follow-up studies discloses a malignant
transformation rate range for combined dysplastic and
nondysplastic lesions of 3.9–17% [1, 19–22]. In the study
by Silverman et al. [1], the risk for cancer progression in
leukoplakias jumped from 17% for all lesions to 36% for
dysplastic lesions whereas the remaining studies failed to
ﬁnd any statistically signiﬁcant increased risk for dys-
plastic lesions [19–22]. Holmstrup et al. [20] demonstrated
a progressive increase in risk correlated with increasing
degrees of dysplasia; however, their population sample was
too low to achieve statistical signiﬁcance. Lastly, it is
noteworthy that the vast majority of precancerous lesions
arising on vocal cord and oral mucosae, regardless of
whether dysplastic changes are extant, do not progress to
carcinoma, at least within the follow-up period speciﬁed in
various reports.
Molecular Biomarkers and Prediction
A variety of proliferation markers, cell cycle cyclin pro-
teins, cyclin kinases, oncoproteins, tumor suppressor
mutations, microsatellite loss of heterozygosity (LOH),
nuclear image parameters and DNA ploidy have been
investigated in both oral and laryngeal carcinomas as well
as dysplasias [17, 23, 24]. These investigations have pro-
vided insight into the molecular mechanisms of
carcinogenesis. It is beyond the scope of this communi-
cation to review this literature, and therefore only those
with promise as potential biomarker predictors will be
discussed. It is noteworthy that immunohistochemical
Table 2 Inter- and intra-rater reliability for dysplasia grades in oral and laryngeal precancerous lesions
Authors Grading system % agreement or Kappa
inter-rater
% agreement or Kappa
intra-rater
McLaren et al. (2000) [8] VC 5 grade WHO 2 grades mild versus severe dysplasia K 0.32
K 0.52
K 0.52
Kujan et al. (2006) [9] OC 2 grades 5 grade WHO K 0.50
Ks 0.22, Kw 0.63
Karabulut et al. (1995) [10] OC 5 grade WHO K 0.27–0.45 (49–59%)
Abbey et al. (1995) [11] OC 4 grade WHO dysplasia versus none 50.5%, 50.8%
81% 80.3%
Fischer et al. 2004 [12] OC 5 grade WHO attending pathologist versus committee K 0.59
Brothwell et al. 2003 [13] OC 5 grade WHO dysplasia versus none modal score standard Kw 0.74 Ks 0.22–0.78
K 0.51
VC = vocal cords, OC = oral cavity; 2 grades––low grade dysplasia/high grade dysplasia; Ljubljana––simple hyperplasia, abnormal hyper-
plasia, atypical hyperplasia, carcinoma in situ; 5 grade WHO––no, mild, moderate, severe dysplasias and carcinoma in situ; 4 grade merges
severe dysplasia with CIS
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are of no prognostic value. Only a marker that can be
identiﬁed in premalignant lesions whose presence predicts
progression offers any meaningful clinical application.
Three approaches have shown utility for upper airway
prognostication including the presence of aneuploidy,
microsatellite instability with LOH at 3p and 9p and
computer generated nuclear image analysis [25–27].
Crissman and Zarbo [25] demonstrated a direct corre-
lation between the presence of aneuploidy and degree of
dysplasia in vocal cord lesions, with all severely dysplastic
lesions being aneuploid. Unfortunately, this study was not
progressive and did not address predictive follow-up
information. No reliable ploidy data have been forthcoming
in any large follow-up studies of oral mucosal dysplastic
lesions. Rosin et al. [26] investigated hyperplastic and mild
dysplastic oral lesions, assessing lesions that progressed to
carcinoma and those that failed to progress using micro-
satellite LOH as a biomarker. They reported a 33 fold
elevated cancer risk for lesions that progressed to cancer
when LOH at 3p and/or 9p coupled with additional losses
at 4q, 8p, 11q, or 17p were identiﬁed. Guillaud et al.
demonstrated that this molecular predictive feature could
be further augmented when combining LOH data with
nuclear image analysis (nuclear phenotype score).
Discussion
Based upon current knowledge, the majority of dysplastic
oral and vocal cord lesions do not progress to squamous
cancer, at least in a mean follow-up period of 7 years and
therefore the terms ‘‘intraepithelial neoplasia’’, either oral
or squamous are to be discouraged for head and neck
lesions. Even the issue of an increase in carcinomatous
transformation prevalence among dysplastic as compared
to benign hyperplastic lesions may be questionable for oral
precancerous lesions. Alternatively, an increased cancer
risk in vocal cord dysplasias is extant over nondysplastic
laryngeal epithelial hyperplasias, although not many long
term follow-up studies have been published.
Some studies do report an increased risk for cancer
when dysplasia is encountered in oral mucosal leukoplak-
ias and erythroplakias, although only one study compared
risk according to grade of dysplasia, failing to ﬁnd a sta-
tistically signiﬁcant correlation. Prognosis and prediction
Table 3 Progression to carcinoma from dysplastic precancerous lesions of the laryngeal and oral mucosa (percentage)
Author Location All lesions dysp/nondysp All dysplasia Grade of dysplasia
a FU (years)
01 2 3 4
Hellquist et al. (1999) [14] Larynx
n = 899 11.2 10.5 0.7 – 1 9.5 – 1.5–12
Isenberg et al. (2008) [15] Larynx – – – – – – –
n = 208 3.8 33 – – – – – –
n = 2188
b 3.7 4 10 18
Ricci et al. (2003) [16] Larynx
n = 207 – 17 – – – – – 7–16
Jeannon et al. (2004) [17] Larynx 24
n = 114 – – – – – –
Gale et al. (2000) [18] Larynx 0.9 – – – 11
Hsue et al. (2007) [19] Oral 3.9 4.8 3 – – – – 3.5
n = 1,458
Holmstrup et al. (2006) [20] Oral 12 12 4 4 8 17 20 6.8
n = 101
Silverman et al. (1984) [1] Oral 17 36 7.2
n = 257
Schepman et al. (1998) [21] Oral
n = 166 2.9 annual 2.4
Hogewind et al. (1989) [22] Oral
n = 46 6.5 2.2 5
a 0 = benign keratosis; 1 = mild dysplasia; 2 = moderate dysplasia; 3 = severe dysplasia; 4 = carcinoma in situ. Ljubljana 0 = simple
hyperplasia; 1 = abnormal hyperplasia; 2,3 = atypical hyperplasia; 4 = carcinoma in situ
b Original cases with literature review
Head and Neck Pathol (2009) 3:63–68 67for cancer progression from precancerous lesions will
continue to be based on features of dysplasia until more
deﬁnitive markers can be discovered. Carcinoma-in situ
should be considered a true ‘‘intraepithelial’’ neoplastic
process and further investigations are needed to assess this
severest variant of dysplastic change as a probable
predictor.
Biomarkers with potential predictive value have been
published and may prove to be clinically relevant. These
include DNA ploidy, computerized nuclear image analysis
and micro satellite instability at 3p and 9p with addition
LOH at other loci.
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